Annual report pursuant to Section 13 and 15(d)
Related Party Transactions (Details) - Affiliated Entity - USD ($) $ in Millions |
12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
May 22, 2021 |
May 22, 2020 |
|
Line of Credit | |||||
Related Party Transaction [Line Items] | |||||
Line of credit facility maximum borrowing capacity | $ 15.0 | $ 15.0 | |||
Long term debt outstanding | $ 0.0 | ||||
Strategic Alliance With Inivata Limited | |||||
Related Party Transaction [Line Items] | |||||
Related party transaction, expenses from transactions with related party | $ 0.8 | ||||
Pharma Service Contracts with CytomX Therapeutics, Inc. | |||||
Related Party Transaction [Line Items] | |||||
Revenue from Related Parties | 0.7 | 0.7 | $ 0.3 | ||
Pharma Services contracts with HOOKIPA Pharma, Inc | |||||
Related Party Transaction [Line Items] | |||||
Revenue from Related Parties | $ 0.4 | $ 0.5 |
X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|